Clarion, Erlinda G.

HRN: 10-73-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CEFTRIAXONE 1G (VIAL)
05/03/2026
05/09/2026
IV
2gm
Q24
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: